Tapewire

NYSE · USD

CSW

CSW INDUSTRIALS, INC.

Export transactions ↓
Tapewire entity
3917
SEC CIK
0001624794
Parsed reports
426

Last 12 months

Inside the activity.

1 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202602
Feb 202602
Mar 202611
Apr 202603
May 202602
Jun 202601
Jul 202601
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2024 Filed Oct 3, 2024 22:46 UTC
Garde DanielleSVP, Chief People Officer
GrantCommon Stock 814 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000077 · wk-form4_1727995581.xml · nonDerivative · entry 1

Garde Danielle · CIK 0001949798 · SVP, Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,454

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:48 UTC
Alverson LukeSVP, GC & Secretary
Tax withholdingCommon Stock 549 $364.56 $200,143.44
Disclosure

SEC source: 0001624794-24-000079 · wk-form4_1727995685.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,572

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:48 UTC
Alverson LukeSVP, GC & Secretary
GrantCommon Stock 814 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000079 · wk-form4_1727995685.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,121

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 23:32 UTC
Armes Joseph BDirector · Chairman, President & CEO
Tax withholdingCommon Stock 2,970 $364.56 $1,082,743.20
Disclosure

SEC source: 0001624794-24-000080 · wk-form4_1727998343.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,698

Read SEC document
October 01, 2024 Filed Oct 3, 2024 23:32 UTC
Armes Joseph BDirector · Chairman, President & CEO
GrantCommon Stock 4,089 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000080 · wk-form4_1727998343.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,668

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:47 UTC Tax withholdingCommon Stock 1,132 $364.56 $412,681.92
Disclosure

SEC source: 0001624794-24-000078 · wk-form4_1727995632.xml · nonDerivative · entry 2

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,572

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:47 UTC GrantCommon Stock 1,389 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000078 · wk-form4_1727995632.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,704

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:45 UTC
Sullivan DonEVP, Chief Strategy Officer
Tax withholdingCommon Stock 1,249 $364.56 $455,335.44
Disclosure

SEC source: 0001624794-24-000076 · wk-form4_1727995519.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,769

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:45 UTC
Sullivan DonEVP, Chief Strategy Officer
GrantCommon Stock 1,333 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000076 · wk-form4_1727995519.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,018

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 130 $344.66 $44,805.80
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 7

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,579

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.37 to $345.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 182 $342.94 $62,415.08
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,709

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.65 to $343.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 78 $342.09 $26,683.02
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,891

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.625 to $342.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 367 $340.57 $124,989.19
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,969

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.21 to $341.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 218 $339.64 $74,041.52
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,336

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.01 to $340.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 20 $337.90 $6,758.00
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,554

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 20:31 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 5 $336.28 $1,681.40
Disclosure

SEC source: 0001624794-24-000074 · wk-form4_1726605096.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,574

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:47 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000073 · wk-form4_1723841259.xml · nonDerivative · entry 1

Griffin Bobby · CIK 0001896568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,448

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 16:42 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000066 · wk-form4_1723840961.xml · nonDerivative · entry 1

Sweezey Jay Kent · CIK 0001691674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,686

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:45 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 125 $314.51 $39,313.75
Disclosure

SEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,579

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.15 to $314.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:45 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 553 $313.39 $173,304.67
Disclosure

SEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,704

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.07 to $313.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:45 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 291 $312.69 $90,992.79
Disclosure

SEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,257

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.06 to $313.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:45 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 31 $311.28 $9,649.68
Disclosure

SEC source: 0001624794-24-000069 · wk-form4_1723841125.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,548

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.81 to $311.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 16:43 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000067 · wk-form4_1723841016.xml · nonDerivative · entry 1

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,919

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:46 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000071 · wk-form4_1723841191.xml · nonDerivative · entry 1

GAMBRELL MICHAEL R · CIK 0001277031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,418

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:41 UTC
Ash Darron KDirector
GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000065 · wk-form4_1723840876.xml · nonDerivative · entry 1

Ash Darron K · CIK 0001519706 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:47 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000072 · wk-form4_1723841222.xml · nonDerivative · entry 1

JOHNSTON TERRY L · CIK 0001565364 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,492

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:46 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000070 · wk-form4_1723841157.xml · nonDerivative · entry 1

LIVINGSTONE LINDA A. · CIK 0001652531 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,918

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 20:44 UTC GrantCommon Stock 360 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000068 · wk-form4_1723841076.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,750

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's 2025 annual meeting of shareholders.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 197 $287.76 $56,688.72
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 8

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,579

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.54 to $288.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 340 $287.13 $97,624.20
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 7

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,776

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.49 to $287.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 160 $285.54 $45,686.40
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,116

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $285.05 to $286.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 162 $284.39 $46,071.18
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,276

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.99 to $284.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 51 $283.30 $14,448.30
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,438

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.94 to $283.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 40 $281.85 $11,274.00
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,489

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.50 to $282.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 40 $280.23 $11,209.20
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,529

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.16 to $280.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 20:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 10 $278.76 $2,787.60
Disclosure

SEC source: 0001624794-24-000052 · wk-form4_1721162359.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,569

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:28 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 24 $268.67 $6,448.08
Disclosure

SEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,579

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:28 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 181 $267.42 $48,403.02
Disclosure

SEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,603

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.115 to $267.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:28 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 325 $266.46 $86,599.50
Disclosure

SEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,784

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.05 to $266.985, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:28 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 88 $265.18 $23,335.84
Disclosure

SEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,109

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.76 to $265.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:28 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 250 $264.22 $66,055.00
Disclosure

SEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,197

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.71 to $264.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 17, 2024 Filed Jun 18, 2024 20:28 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 132 $263.16 $34,737.12
Disclosure

SEC source: 0001624794-24-000051 · wk-form4_1718742512.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,447

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.56 to $263.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2024 Filed May 30, 2024 23:38 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 121 $258.71 $31,303.91
Disclosure

SEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,579

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.46 to $259.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2024 Filed May 30, 2024 23:38 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 378 $257.77 $97,437.06
Disclosure

SEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,700

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.38 to $258.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2024 Filed May 30, 2024 23:38 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 250 $257.03 $64,257.50
Disclosure

SEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,078

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.31 to $257.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 30, 2024 Filed May 30, 2024 23:38 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 251 $255.52 $64,135.52
Disclosure

SEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,328

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.21 to $256.205, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 29, 2024 Filed May 30, 2024 23:42 UTC
UNDERWOOD JEFFSVP, GM Contractor Solutions
GrantPerformance Rights · Derivative 954 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000042 · wk-form4_1717112514.xml · derivative · entry 1

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 954

Underlying: Common Stock · 954 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
May 29, 2024 Filed May 30, 2024 23:35 UTC
Garde DanielleSVP, Chief People Officer
GrantPerformance Rights · Derivative 1,006 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000036 · wk-form4_1717112139.xml · derivative · entry 1

Garde Danielle · CIK 0001949798 · SVP, Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,006

Underlying: Common Stock · 1,006 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
May 29, 2024 Filed May 30, 2024 23:39 UTC
Alverson LukeSVP, GC & Secretary
GrantPerformance Rights · Derivative 1,093 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000039 · wk-form4_1717112368.xml · derivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,093

Underlying: Common Stock · 1,093 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
May 29, 2024 Filed May 30, 2024 23:38 UTC
Armes Joseph BDirector · Chairman, President & CEO
GrantPerformance Rights · Derivative 8,236 $0.00 $0.00
Disclosure

SEC source: 0001624794-24-000038 · wk-form4_1717112316.xml · derivative · entry 7

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,236

Underlying: Common Stock · 8,236 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F6 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F6 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.